glp 1 and kidney GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal Glucagon-like peptide-1 receptor signaling modifies
Description
Yoshino Y, Ishisaka M, Tsujii S, Shimazawa M, Hara H
During this period, there was a significant decrease in 24-hour urine oxalate (4016 to 3211 mg/d, P = 0.002), sulfate (2110 to 179 mmol/d, P = 0005), and ammonium (3522 to 2915 mEq/d, P = 0.01) excretion rates
But here's the problem: protein is the hardest macronutrient to hit within a reduced-calorie day, and it's the one with the most serious consequences if you consistently miss it
V., Koblan, L
Unlike other GLP-1 injections, Saxenda is meant to be taken daily
